AUS
NZ
UK
CA
USA
IND
Healthcare
ASX 200 Today: SIG Tracks Chemist Warehouse Expansion
May 05, 2026 10:31 AM AEST| By SamSigma Healthcare gains attention in ASX 200 today as Chemist Warehouse expands internationally, highlighting healthcare distribution and retail pharmacy network developments.
ASX 300 Healthcare Focus as Careteq Expands Share Base
May 05, 2026 10:06 AM AEST| By SamCareteq advances capital structure through share quotation plans, highlighting healthcare technology sector developments and digital service expansion within ASX 300.
Can These ASX Healthcare Stocks Stage a Dramatic Comeback?
May 05, 2026 09:52 AM AEST| By SamEpiminder and Saluda Medical draw focus as healthcare innovators, with clinical progress and commercial momentum shaping their outlook amid ongoing market volatility.
ASX 200 Healthcare Metrics as COH Draws Focus
May 04, 2026 07:24 PM AEST| By SamCochlear reflects healthcare sector metrics within ASX 200 and ASX 300, highlighting earnings structure, product adoption, and research-driven innovation shaping medical device industry trends.
ASX 200 Update: Stocks with Rising Short Interest
May 04, 2026 05:00 PM AEST| By SamShort interest trends across ASX-listed healthcare, mining, consumer, and tech firms highlight shifting market sentiment influenced by sector developments and operational updates.
ASX 200 Healthcare Focus as COH Gains Attention
May 04, 2026 03:21 PM AEST| By SamCochlear reflects healthcare sector innovation within ASX 200 and ASX 300, highlighting medical technology development, global operations, and research-driven advancements shaping the market.
ASX 200 Healthcare Shift: Sector Leaders Drive Market Moves
May 04, 2026 02:47 PM AEST| By SamHealthcare sector developments highlight the role of leading companies in shaping ASX index movement, reflecting global demand and ongoing innovation within medical and biotechnology industries.
ASX Biotech Play Targets Wellness Boom with MeTime Launch
May 04, 2026 02:31 PM AEST| By SamEZZ enters the wellness market with its MeTime range, combining biotech research and consumer health trends to target growing demand for functional, science-backed supplements.
ASX Biotech Shake-Up: Arovella Board Exit Sparks Strategic Reset
May 04, 2026 02:20 PM AEST| By SamArovella undergoes major board changes after shareholder action, with a strategic review underway as the biotech company refocuses on its cell therapy pipeline and future growth.
ASX 200 Healthcare Giant Faces Profit Pressure Despite Growth
May 04, 2026 11:02 AM AEST| By SamSonic Healthcare draws attention as revenue growth contrasts with falling profits, highlighting margin pressure, debt considerations, and the need for improved operational efficiency.
ASX 200 Focus: 4DMedical-GSK Imaging Deal Insight
May 03, 2026 03:55 PM AEST| By Sam4DMedical’s collaboration with GSK highlights the growing role of advanced imaging in respiratory research, reflecting broader innovation trends within the ASX healthcare sector.
Why This ASX 200 Healthcare Stock Still Draws Attention
May 02, 2026 03:15 PM AEST| By SamPro Medicus remains in focus as healthcare demand, digital innovation, and ethical investing trends support long-term sector interest despite recent share price volatility.
LTR Pharma’s Dual US Path Sparks Market Attention
May 01, 2026 07:57 PM AEST| By SamLTR Pharma highlights SPONTAN clinical progress, US expansion strategy, and funding strength, reinforcing its position in innovative drug delivery and evolving healthcare developments.
Healthcare Focus on ASX 200: LTR Pharma Advances with Clinical Buzz
May 01, 2026 07:52 PM AEST| By Team Kalkine MediaLTR Pharma highlights healthcare sector momentum on the ASX, while materials stocks gain traction amid commodity strength and small-cap activity shapes early trading trends.
4DMedical Gains Momentum After Major Pharma Tie-Up
May 01, 2026 05:24 PM AEST| By Sam4DMedical secures a new pharma contract, boosting its lung imaging platform adoption and reinforcing long-term growth themes amid short-term market volatility.
CSL Weakness Sparks ASX 200 Valuation Debate
May 01, 2026 04:23 PM AEST| By Team Kalkine MediaA leading healthcare stock faces renewed scrutiny as valuation gaps and growth expectations drive market debate, reflecting shifting sentiment and broader sector dynamics.
CSL Back in Spotlight: Valuation Gap Sparks Fresh Debate
May 01, 2026 03:22 PM AEST| By SamCSL re-enters focus as valuation discussions deepen, highlighting growth drivers, market sentiment, and long-term positioning within the evolving global healthcare landscape.
Cochlear ASX 200 Today Market Update in All Ords
May 01, 2026 02:05 PM AEST| By SamCochlear’s recent movement highlights healthcare sector trends within ASX 200 Today and All Ords, reflecting innovation, operational activity, and evolving market dynamics.
-Copy_01_27_2025_20_08_39_516693.jpg)
ASX 200 Healthcare Boost: ResMed Delivers Strong Earnings Momentum
May 01, 2026 10:20 AM AEST| By SamResMed delivers strong quarterly growth supported by global demand, innovation, and digital health expansion, reinforcing its position within the evolving healthcare sector.
ASX Healthcare Move: Paradigm Expands Share Base for Growth
May 01, 2026 10:04 AM AEST| By SamParadigm Biopharmaceuticals expands its share base to support development, improve liquidity, and strengthen funding flexibility, reflecting ongoing capital needs within the healthcare and biotech sector.
Advertise your brand on Kalkine Media